Showing results (111-120 of 277) with videos related to
Sort By:
Pageof 28
Journal of the American Academy of Dermatology|January 16, 2013
Cutaneous manifestations of gastrointestinal disease: part IKejal R Shah, C Richard Boland, Mahir Patel, et al.Journal of Drugs in Dermatology : JDD|May 10, 2014
Analysis of body regions and components of PASI scores during adalimumab or methotrexate treatment for patients with moderate-to-severe psoriasisAlexander A Navarini, Yves Poulin, Alan Menter, et al.Proceedings (Baylor University. Medical Center)|May 6, 2021
Penile calciphylaxis with extragenital gangreneMarcus Zaayman, Annika Silfvast-Kaiser, Edgar Rodriguez, et al.Proceedings (Baylor University. Medical Center)|April 22, 2020
Diffuse dermal angiomatosis of the breastNicholas Nguyen, Annika S Silfvast-Kaiser, Jillian Frieder, et al.Archives of Dermatology|December 17, 2003
Treatment of psoriasis with alefacept: correlation of clinical improvement with reductions of memory T-cell countsKenneth B Gordon, Akshay K Vaishnaw, John O'Gorman, et al.Seminars in Cutaneous Medicine and Surgery|April 4, 2018
Treating to Target-A Realistic Goal in Psoriasis?Kenneth B Gordon, April W Armstrong, M Alan Menter, et al.Journal of the American Academy of Dermatology|February 11, 2011
Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions, Alan Menter, Neil J Korman, et al.Journal of Drugs in Dermatology : JDD|August 19, 2016
Aerosol Foam Formulation of Fixed Combination Calcipotriene Plus Betamethasone Dipropionate is Highly Efficacious in Patients With Psoriasis Vulgaris: Pooled Data From Three Randomized Controlled StudiesLinda Stein Gold, Mark Lebwohl, Alan Menter, et al.Journal of Drugs in Dermatology : JDD|June 3, 2020
Importance of Complete Skin Clearance in Psoriasis as a Treatment Goal: Implications for Patient-Reported OutcomesAndrew Blauvelt, Jashin J Wu, April Armstrong, et al.Journal of Drugs in Dermatology : JDD|October 15, 2016
Adalimumab Treatment in Women With Moderate-to-Severe Hidradenitis Suppurativa from the Placebo-Controlled Portion of a Phase 2, Randomized, Double-Blind StudyAlice Gottlieb, Alan Menter, April Armstrong, et al.Pageof 28